Methylprednisolone Recruiting Phase 2 Trials for Congenital Hypoplastic Anemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia